Market
Scenario
The nasal route administration is experiencing
tremendous growth due to its noninvasive nature consequently reducing pain and
threat of infections. It allows the patient to self-administer drugs thus not
requiring any external help. The high
vasculature, high permeability, and low enzymatic environment of nasal cavity are perfectly apt for systemic
delivery of drug molecules via nose. There is no risk of drug
destruction by hydrogen chloride (HCl) present in the stomach thereby
increasing bioavailability which reduces the dosage of the drug. This, in turn, leads to proportional reduction in side effects.
Increasing popularity of over-the-counter nasal
drugs such as inhalers for the common
cold is also propel the market in an upward manner. Nasal drugs prove to be
advantageous for the market, with a plethora
of factors like good penetration of the drugs into the nasal cavity, improving
patient compliance, rapid absorption, onset
of action, and requirement of low dosage.
Key
Players
Novartis
AG
Pfizer,
Inc.
Sanofi-Aventis
Merck
& Co., Inc.
AptarGroup
Inc.
Johnson
& Johnson Services, Inc.
GlaxoSmithKline
plc
Becton Dickson & Company
Segments:
Middle
East and Africa nasal drug delivery market has been segmented on the basis of
dosage form which comprises of drops, sprays, powder, gels and ointments. On
the basis of system, market is segmented into unit dose, multi-dose and metered
dose. On the basis of delivery technologies; market is segmented into spray,
nebulizers and other. On the basis of therapeutic applications; market is
segmented into rhinitis, congestion, vaccinations and others.
Drivers
and Restraints
The market for nasal drug delivery is growing
remarkably with a consistently good CAGR due to the benefits accompanying nasal
drugs. Other driving factors include innovation of drugs which are
absorbed easily from the nasal route, innovations in advanced products which
allow the delivery of precise doses and also ease of administration. However,
the restraints that threaten the growth of the market are irritation of the
nasal route and the low dose of the drug that can be delivered as compared to other
routes of administration. Other constraints include concurrent low popularity of the route which
reduces economies of scale in producing these delivery devices and low
awareness. According to an extensive
report by Market Research Future (MRFR), the
Middle East and Africa nasal drug delivery market is presumed to reach around USD 1.59 billion in 2022 surging at a
CAGR of 8.1% from 2017 to 2022. The
market was estimated to be worth USD 1 billion in 2015.
Regional
Analysis
UAE is
the largest market for nasal drug delivery in entire Middle East and Africa
nasal drug delivery Market closely followed by Egypt. The rest of Africa’s
market is growing at a very fast rate due to huge unmet medical needs and
growing popularity of nasal route.
Browse Complete 84 Pages Premium Research Report
Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/nasal-drug-delivery-market-2696
Detailed
Table of Contents:
1. Introduction
1.1
Definition
1.2
Scope Of Study
1.2.1
Research Objective
1.2.2
Assumptions & Limitations
1.2.2.1
Assumptions
1.2.2.2
Limitations
1.3
Market Structure
2. Research Methodology
2.1
Research Process
2.2
Primary Research
2.3
Secondary Research
3 Market Dynamics
3.1
Drivers
3.2
Restraints
3.3
Opportunities
3.4
Challenges
3.5
Macroeconomic Indicators
...Continued
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment